Investing.com -- Sarepta Therapeutics came under pressure after two brokerages slashed their price targets and downgraded the stock, flagging mounting safety, regulatory, and credibility concerns ...

Welcome to our live blog covering the latest from across Africa. Follow real-time updates on political transitions, security ...